New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 18, 2014
09:04 EDTABBV, ENTAEnanta Pharmaceuticals could be acquired by AbbVie, says JMP Securities
Sterne Agee believes that coming HCV approvals could entice Abbvie (ABBV) to buy Enanta Pharmaceuticals (ENTA). The firm raised its price target on Enanta to $50 from $25 and recommends owning Enanta at current levels.
News For ENTA;ABBV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 1, 2015
05:43 EDTABBVEli Lilly assumed with an Overweight from Equal Weight at Barclays
Barclays analyst Geoff Meacham upgraded Eli Lilly (LLY) to Overweight after assuming coverage of the name. Good execution for Cyramza and Jardiance should drive continued share outperformance, Meacham tells investors in a research note. He raised his price target for shares to $95 from $75. Lilly closed yesterday down $1.43 to $82.22. The analyst this morning also upgraded Johnson & Johnson (JNJ) and Merck (MRK) to Overweight and downgraded AbbVie (ABBV) to Equal Weight.
05:40 EDTABBVAbbVie assumed with an Equal Weight from Overweight at Barclays
Subscribe for More Information
November 30, 2015
15:15 EDTABBVBristol-Myers, AbbVie confirm FDA approval of Empliciti for multiple myeloma
Subscribe for More Information
November 23, 2015
16:06 EDTENTAEnanta reports Q4 EPS 29c, consensus 15c
Subscribe for More Information
15:28 EDTENTANotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Palo Alto (PANW), consensus 32c... Copart (CPRT), consensus 43c... Brocade (BRCD), consensus 24c... Post Holdings (POST), consensus 29c... YY (YY), consensus 82c... Dycom (DY), consensus $1.01... Cubic (CUB), consensus 96c... Enanta (ENTA), consensus 15c.
November 19, 2015
07:36 EDTABBVFDA Pediatric Advisory Committee to hold a meeting
Subscribe for More Information
November 18, 2015
07:43 EDTABBVJefferies to hold a conference
Subscribe for More Information
November 17, 2015
10:09 EDTABBVAbbVie management to meet with Jefferies
Subscribe for More Information
08:05 EDTABBVInfinity reaches target enrollment in Phase 3 study of duvelisib
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use